Showing results (1-10 of 120) with videos related to
Sort By:
Pageof 12
Clinical Pharmacology and Therapeutics|May 13, 2016
CD19-Targeted chimeric antigen receptor-modified T-cell immunotherapy for B-cell malignanciesC J Turtle, S R Riddell, D G MaloneyLeukemia|September 16, 2015
Chimeric antigen receptor-modified T cells derived from defined CD8+ and CD4+ subsets confer superior antitumor reactivity in vivoD Sommermeyer, M Hudecek, P L Kosasih, et al.Seminars in Respiratory Infections|December 1, 1995
Pathogenesis of cytomegalovirus pneumonia in immunocompromised hostsS R RiddellCurrent Opinion in Hematology|July 10, 1999
Advances in the immunotherapy of hematologic malignancies: cellular and humoral approachesD G MaloneyCurrent Opinion in Hematology|September 25, 1998
Advances in immunotherapy of hematologic malignanciesD G MaloneyNature Communications|September 27, 2024
Histone marks identify novel transcription factors that parse CAR-T subset-of-origin, clinical potential and expansionS Fiorenza, Y Zheng, J Purushe, et al.Current Drug Targets|January 24, 2004
Dendritic cells in tumor immunology and immunotherapyC J Turtle, D N J HartPageof 12